Pulmatrix, Inc. Common Stock (PULM)
Pulmatrix, Inc. (PULM) is a clinical-stage biopharmaceutical company focused on developing inhaled therapies for respiratory diseases. The company specializes in advanced dry powder and nasal spray formulations to address conditions such as respiratory infections and inflammation, leveraging its proprietary iSPERSE technology platform.
Company News
Pulmatrix, Inc. (PULM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Gainers ECMOHO Limited (NASDAQ: MOHO) shares rose 47% to $0.2149 in pre-market trading. Vaccitech plc (NASDAQ: VACC) shares rose 25% to $5.89 in pre-market trading. Vaccitech recently posted Q2 earnings of $0.41 per share. AIM ImmunoTech Inc. (NYSE: AIM) rose 23.8% to $0.87 in pre-market trading. AIM Immunotech recently reported commencement of ...